EUVIMEDEUVIMED entdecken
Editorial

COVID ‐19 vaccination and autoimmunity: Causality, precipitation or chance association?

Prakashini Mv iD, Sakir Ahmed iD

International Journal of Rheumatic Diseases · 2023

DOI: 10.1111/1756-185x.14893 ↗

Kurz gefasst

Editorial in der Zeitschrift International Journal of Rheumatic Diseases, 2023. Verfasst von Prakashini Mv und 1 weiteren Autor:innen. Beteiligte Einrichtung: Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, India. Hauptthemen laut MEDLINE: COVID-19, Autoimmune Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this issue, Chen and associates1 have presented a unique systematic review of autoimmune arthritis occurring post-COVID vaccination. They could identify 39 such cases in the literature of which 10 were diagnosed as adult-onset Still's disease (AOSD). The numbers seem small compared to the magnitude of COVID vaccination on a global scale. However, if the vaccines are actually shown to cause autoimmunity, it may boil down to ethics issues as an extension of the trolley problem that has plagued dengue vaccine development.2 The technocrats and bureaucrats will have to decide how many people can be "given" autoimmune arthritis in order to prevent how many deaths. No one would want that responsibility and there is no easy answer. Also, there are certain people ("anti-vaxxers") who may use such arguments to spread misinformation and amplify fear regarding vaccine safety.3 These concerns weigh heavy on the minds of authors, reviewers, and editors alike. However, science has to take precedence. Any possible adverse effects attributable to even proven life-saving vaccines must be investigated very thoroughly. Chen and associates have taken the first step by collating the data. Next, the scientific community must get together to make a framework to actively capture all such cases and follow them prospectively. Wherever ethical and feasible, samples from such individuals should be collected and subjected to a multi-omics and systems biology approach; including, but not limited to, genetics, epigenetics (methylomics), transcriptomics, and T cell receptor repertoire sequencing. For a systems biology approach, such a cohort of 39 may be more than sufficient. Machado et al4 have mentioned that the rates of disease flare-ups post-vaccination in patients with autoimmune rheumatic diseases (AIRDs) are not different from similar but unvaccinated people with AIRD. So, the biggest question here is whether these autoimmune arthritides that have a temporal association with COVID vaccination, are occurring in addition to the background incidence of such cases. With billions of vaccines being administered worldwide, an apparent temporal association with new-onset arthritis may not be unexpected. We also have to consider the alternate hypothesis that the vaccines might have actually led to precipitation or initiation of autoimmunity. These cases may be an immune phenomenon to the SARS-CoV2 infection or the vaccines and/or its adjuvants or a "second-hit" to a pre-existent genetic risk predisposing to inflammatory arthritis like rheumatoid arthritis (RA).5 Whether it is a reaction to the viral or vaccine components, similar pathogenic mechanisms6 have been proposed for the umbrella of "post-viral arthritis", "vaccine-induced arthritis" or more commonly "post-COVID reactive arthritis". For post-COVID or post-vaccine "reactive arthritis", contrary to the traditionally described post-enteric or post-venereal ReA,7 the exact timeline from the infection or vaccination to the development of arthritis has not been standardized. The mean duration between the "trigger" vaccination and the onset of inflammatory arthritis in the systematic review is 7.4 ± 5.5 days. However, the usual time duration between the inciting event and the development of ReA traditionally is 3–4 weeks, which is the amount of time required for a T cell-mediated event to become clinically evident. This may imply that the arthritis is merely a hypersensitivity response to the vaccine components or the adjuvants, rather than reactive arthritis per se. Many of the "post-COVID ReA" have resolved within 6–12 weeks, whereas at least a third of traditional ReA becomes chronic.7 Even the post-vaccination flares in patients with pre-existing AIRD in the COVAX registry were non-severe and completely resolved without sequelae.4 Another explanation might be that these individuals were already at risk for rheumatoid or other arthritides, with subclinical pathogenesis going on, and this was unmasked into clinical synovitis after exposure to the vaccine antigens and adjuvants. The case series covered in the review by Chen and associates provided mostly short-term data. There is a lack of clarity if any of these manifestations relapsed after resolution and how many were chronic. Patients have been reported to have resolution of arthritis after 3 days of dexamethasone.8 Another large series (66 patients) of post-vaccination arthritis had reported that the main presentation was polymyalgia rheumatica-like (PMR) with shoulder girdle stiffness; however, the acute phase response was not dramatically high as seen in classical PMR cases.9 Thus, it may not be used to exclude a nocebo effect in some of the patients. The effect of disease needs to be understood as well. Disease with a predominant autoinflammatory phenotype (more of innate immunity activation) such as Beçhet's disease or familial Mediterranean fever have reported more post-vaccine flares.10, 11 Thus, the jury is still out on whether COVID-19 vaccines precipitate autoimmunity or not. The safety of COVID vaccination in both children and adults with autoimmunity has been proven beyond doubt.12, 13 This also adds ground to the hypothesis that the vaccines are less likely to precipitate autoimmunity but rather may be a chance temporal association or an unmasking phenomenon. The current evidence can be used to support alternating viewpoints. Thus, it is imperative to chalk out an international plan to document and follow up all autoimmune phenomena reported after COVID-19 vaccination. An updated definition of "post-COVID reactive arthritis" is needed if this should cover post-vaccination arthritis.14 This needs willpower, international collaboration, and funding. It is best to get this question cleared before another pandemic starts with a race for new vaccines. Both authors contributed equally in the ideas, conception, drafting and revision of the manuscript. The authors have nothing to report. The authors declare no conflicts of interest. Data sharing is not applicable to this article as no new data were created or analyzed in this study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Autoimmune DiseasesHumansAutoimmunityCOVID-19 VaccinesVaccination

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, India.

ORCID-Profile: Prakashini Mv, Sakir Ahmed

Zitieren

APA

Mv, P., & Ahmed, S. (2023). COVID ‐19 vaccination and autoimmunity: Causality, precipitation or chance association?. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.14893

Vancouver

Mv P, Ahmed S. COVID ‐19 vaccination and autoimmunity: Causality, precipitation or chance association?. International Journal of Rheumatic Diseases. 2023. doi:10.1111/1756-185x.14893

BibTeX
@article{Mv2023,
  author = {Mv, Prakashini and Ahmed, Sakir},
  title = {COVID ‐19 vaccination and autoimmunity: Causality, precipitation or chance association?},
  journal = {International Journal of Rheumatic Diseases},
  year = {2023},
  doi = {10.1111/1756-185x.14893}
}
Kostenlos starten →